Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GIP/GLP-1s The newest class of drugs that treat both type 2 diabetes and obesity work with both of the main digestive hormones that tell your body to make insulin: GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
The findings suggest additional mental health benefits of GLP-1 drugs beyond alcohol use and addiction
These include GLP-1 medications like semaglutide and tirzepatide, when clinically appropriate
However, this is not always possible
Biomarker and Genetic Context: Why Personalization Matters Individual differences in oxidative stress, inflammatory markers, and genetic predispositions in metabolic pathways may influence how well GLP-1 therapy works and tolerability
Our doctors design personalized treatment plans based on your digestive health response, symptom resolution, and overall wellness objectives, adjusting duration for optimal outcomes
